OTCMKTS:EVIO

EVIO Competitors

$0.0020
0.00 (0.00 %)
(As of 04/20/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.00
Now: $0.00
$0.00
50-Day Range N/A
52-Week Range
$0.00
Now: $0.00
$0.03
Volume18.76 million shs
Average Volume44.64 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

EVIO (OTCMKTS:EVIO) Vs. ABAHF, ACRGF, APPB, AYRSF, CANB, and CNTMF

Should you be buying EVIO stock or one of its competitors? Companies in the industry of "drug manufacturers - specialty & generic" are considered alternatives and competitors to EVIO, including Abacus Health Products (ABAHF), Acreage (ACRGF), Applied Biosciences (APPB), Ayr Strategies (AYRSF), Can B (CANB), and Cansortium (CNTMF).

Abacus Health Products (OTCMKTS:ABAHF) and EVIO (OTCMKTS:EVIO) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, profitability, earnings, risk and analyst recommendations.

Profitability

This table compares Abacus Health Products and EVIO's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Abacus Health ProductsN/AN/AN/A
EVION/AN/AN/A

Valuation & Earnings

This table compares Abacus Health Products and EVIO's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Abacus Health ProductsN/AN/AN/AN/AN/A
EVION/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of recent recommendations for Abacus Health Products and EVIO, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Abacus Health Products0000N/A
EVIO0000N/A

Acreage (OTCMKTS:ACRGF) and EVIO (OTCMKTS:EVIO) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, profitability, earnings, risk and analyst recommendations.

Profitability

This table compares Acreage and EVIO's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
AcreageN/AN/AN/A
EVION/AN/AN/A

Valuation & Earnings

This table compares Acreage and EVIO's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AcreageN/AN/AN/AN/AN/A
EVION/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of recent recommendations for Acreage and EVIO, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Acreage01202.67
EVIO0000N/A

Acreage presently has a consensus price target of $8.4333, indicating a potential upside of 204.45%. Given Acreage's higher possible upside, equities research analysts plainly believe Acreage is more favorable than EVIO.

Summary

Acreage beats EVIO on 2 of the 2 factors compared between the two stocks.

Applied Biosciences (OTCMKTS:APPB) and EVIO (OTCMKTS:EVIO) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, profitability, earnings, risk and analyst recommendations.

Profitability

This table compares Applied Biosciences and EVIO's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Applied BiosciencesN/AN/AN/A
EVION/AN/AN/A

Valuation & Earnings

This table compares Applied Biosciences and EVIO's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Applied BiosciencesN/AN/AN/AN/AN/A
EVION/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of recent recommendations for Applied Biosciences and EVIO, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Applied Biosciences0000N/A
EVIO0000N/A

Ayr Strategies (OTCMKTS:AYRSF) and EVIO (OTCMKTS:EVIO) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, profitability, earnings, risk and analyst recommendations.

Valuation & Earnings

This table compares Ayr Strategies and EVIO's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ayr StrategiesN/AN/AN/AN/AN/A
EVION/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of recent recommendations for Ayr Strategies and EVIO, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ayr Strategies01602.86
EVIO0000N/A

Ayr Strategies presently has a consensus price target of $34.8571, indicating a potential upside of 63.96%. Given Ayr Strategies' higher possible upside, equities research analysts plainly believe Ayr Strategies is more favorable than EVIO.

Profitability

This table compares Ayr Strategies and EVIO's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ayr StrategiesN/AN/AN/A
EVION/AN/AN/A

Summary

Ayr Strategies beats EVIO on 2 of the 2 factors compared between the two stocks.

EVIO (OTCMKTS:EVIO) and Can B (NASDAQ:CANB) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, risk, dividends, valuation and analyst recommendations.

Valuation and Earnings

This table compares EVIO and Can B's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
EVION/AN/AN/AN/AN/A
Can BN/AN/AN/AN/AN/A

Analyst Ratings

This is a breakdown of current recommendations and price targets for EVIO and Can B, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
EVIO0000N/A
Can B0000N/A

Profitability

This table compares EVIO and Can B's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
EVION/AN/AN/A
Can BN/AN/AN/A

EVIO (OTCMKTS:EVIO) and Cansortium (OTCMKTS:CNTMF) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, risk, dividends, valuation and analyst recommendations.

Valuation and Earnings

This table compares EVIO and Cansortium's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
EVION/AN/AN/AN/AN/A
CansortiumN/AN/AN/AN/AN/A

Analyst Ratings

This is a breakdown of current recommendations and price targets for EVIO and Cansortium, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
EVIO0000N/A
Cansortium00103.00

Cansortium has a consensus price target of $1.20, indicating a potential upside of 6.10%. Given Cansortium's higher possible upside, analysts clearly believe Cansortium is more favorable than EVIO.

Profitability

This table compares EVIO and Cansortium's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
EVION/AN/AN/A
CansortiumN/AN/AN/A

Summary

Cansortium beats EVIO on 2 of the 2 factors compared between the two stocks.


EVIO Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
ABAHF
Abacus Health Products
0.4$4.84flat$0.00N/A0.00News Coverage
Gap Up
Acreage logo
ACRGF
Acreage
1.2$2.77flat$0.00N/A0.00
Applied Biosciences logo
APPB
Applied Biosciences
0.5$0.21flat$0.00N/A0.00Increase in Short Interest
Gap Up
AYRSF
Ayr Strategies
1.4$21.26flat$0.00N/A0.00
Can B logo
CANB
Can B
0.4$0.52flat$0.00N/A0.00Gap Down
Cansortium logo
CNTMF
Cansortium
0.7$1.13flat$0.00N/A0.00Gap Down
Charlotte's Web logo
CWBHF
Charlotte's Web
1.3$3.90flat$0.00N/A0.00
Choom logo
CHOOF
Choom
0.5$0.09flat$0.00N/A0.00Gap Down
CPHRF
Cipher Pharmaceuticals
1.2$1.07flat$0.00N/A0.00
CLS Holdings USA logo
CLSH
CLS Holdings USA
0.7$0.20flat$0.00N/A0.00News Coverage
Gap Up
Cosmos logo
COSM
Cosmos
0.5$6.30flat$0.00N/A0.00High Trading Volume
Increase in Short Interest
Gap Down
Cresco Labs logo
CRLBF
Cresco Labs
1.3$11.25flat$0.00N/A0.00
Curaleaf logo
CURLF
Curaleaf
1.6$12.77flat$0.00N/A0.00
HMDEF
DionyMed Brands
0.5N/AN/A$0.00N/A0.00High Trading Volume
Easton Pharmaceuticals logo
EAPH
Easton Pharmaceuticals
0.5$0.00flat$0.00N/A0.00Gap Down
Elixinol Global logo
ELLXF
Elixinol Global
0.8$0.15flat$0.00N/A0.00
Flower One logo
FLOOF
Flower One
0.4$0.19flat$0.00N/A0.00Gap Up
Golden Leaf logo
GLDFF
Golden Leaf
0.5$0.05flat$0.00N/A0.00Gap Up
Green Growth Brands logo
GGBXF
Green Growth Brands
0.4$0.01flat$0.00N/A0.00
Green Thumb Industries logo
GTBIF
Green Thumb Industries
1.7$26.82flat$0.00N/A0.00Gap Down
GTEC logo
GGTTF
GTEC
0.6$0.57flat$0.00N/A0.00Gap Up
Harvest Health & Recreation logo
HRVSF
Harvest Health & Recreation
1.3$2.85flat$0.00N/A0.00Gap Up
Hemp Naturals logo
HPMM
Hemp Naturals
0.6$0.01flat$0.00N/A0.00
Hexo logo
HYYDF
Hexo
0.6N/AN/A$0.00N/A0.00
Hikma Pharmaceuticals logo
HKMPY
Hikma Pharmaceuticals
0.4$65.83flat$0.00N/A0.00Gap Down
iAnthus Capital logo
ITHUF
iAnthus Capital
0.6$0.18flat$0.00N/A0.00Gap Up
Icanic Brands logo
ICNAF
Icanic Brands
0.6$0.27flat$0.00N/A0.00Gap Up
KNHBF
ICC International Cannabis
0.6N/AN/A$0.00N/A0.00
Invictus MD Strategies logo
IVITF
Invictus MD Strategies
0.6$0.04flat$0.00N/A0.00
Isodiol International logo
ISOLF
Isodiol International
0.4$0.06flat$0.00N/A0.00Gap Down
Khiron Life Sciences logo
KHRNF
Khiron Life Sciences
1.4$0.38flat$0.00N/A0.00Gap Up
KHTRF
Knight Therapeutics
1.2$4.15flat$0.00N/A0.00
Marijuana Company of America logo
MCOA
Marijuana Company of America
0.5$0.01flat$0.00N/A0.00Gap Down
Medical Marijuana logo
MJNA
Medical Marijuana
0.6$0.05flat$0.00N/A0.00News Coverage
Gap Down
MediPharm Labs logo
MEDIF
MediPharm Labs
1.2$0.37flat$0.00N/A0.00Increase in Short Interest
MedMen Enterprises logo
MMNFF
MedMen Enterprises
0.8$0.26flat$0.00N/A0.00Gap Down
MERCK Kommanditgesellschaft auf Aktien logo
MKKGY
MERCK Kommanditgesellschaft auf Aktien
0.5$35.05flat$0.00N/A0.00Increase in Short Interest
MJardin Group logo
MJARF
MJardin Group
1.1$0.06flat$0.00N/A0.00
MYHI
Mountain High Acquisitions
0.5$0.02flat$0.00N/A0.00Gap Up
PHCEF
Pharmacielo
0.7$1.34flat$0.00N/A0.00Gap Up
Plus Products logo
PLPRF
Plus Products
1.1$0.51flat$0.00N/A0.00Gap Down
Premier Biomedical logo
BIEI
Premier Biomedical
0.5$0.00flat$0.00N/A0.00Gap Up
PCYN
Procyon
0.4$0.60flat$0.00N/A0.00
Pure Global Cannabis logo
PRCNF
Pure Global Cannabis
0.7$0.01flat$0.00N/A0.00
SANP
Santo Mining
0.5$0.00flat$0.00N/A0.00
Shionogi & Co., Ltd. logo
SGIOY
Shionogi & Co., Ltd.
0.5$12.76flat$0.00N/A0.00Increase in Short Interest
News Coverage
Gap Up
DNPUF
Sumitomo Dainippon Pharma
0.5$17.40flat$0.00N/A0.00News Coverage
TerrAscend logo
TRSSF
TerrAscend
1.7$9.95flat$0.00N/A0.00
The Flowr logo
FLWPF
The Flowr
1.5$0.22flat$0.00N/A0.00Gap Up
The Supreme Cannabis logo
SPRWF
The Supreme Cannabis
1.2$0.28flat$0.00N/A0.00
This page was last updated on 4/21/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.